FDA ushers Merck's star cancer drug Keytruda toward another key checkpoint
Merck counts 22 approved indications for Keytruda across 14 different cancer types. It is now being ushered toward one more.
The PD-1 blockbuster has been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
